Stock Sale, Buyback News

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of...

MEXICO CITY--(BUSINESS WIRE)--Corporación Inmobiliaria Vesta, S.A.B. de C.V. (“Vesta”) (NYSE: VTMX; BMV: VESTA), a fully-integrated, internally managed real estate company that owns, manages, develops and leases industrial properties in Mexico, today announced that, in connection with its previously completed global offering, the international underwriters have exercised their option to purchase an additional 7,749,200 common shares represented by American Depositary Shares, or ADS, at a price...

LONDON--(BUSINESS WIRE)--Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced the completion of its subscription for $1 billion of non-voting exchangeable perpetual preferred stock issued by Howard Hughes Holdings Inc. (NYSE: HHH) (“HHH”) (the “PSH Preferred Stock”) in connection with the completion of HHH's acquisition by its subsidiary Howard Hughes Insurance Holdings, LLC (“InsuranceCo”) of Vantage Group Holdings, Ltd. (“Vantage”), a privately held specialty insurance an...

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on June 1, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock options to purchase an aggregate of 353,000 shares of common stock to twenty new employees under the Company’s 2024 Induc...

BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that, effective on June 1, 2026, the Compensation Committee of Sensei’s Board of Directors granted three new employees options to purchase an aggregate of 19,300 shares of the Company’s common stock in connection with their employment (collectively, the “Option Awards”). The Option Awards were granted pursuant to the Company’s 2026 Inducement Plan as a material inducement to the individuals entering employment...

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial Markets Authority (AMF) via ONDE, the centralized information filing system, regarding the sale of a new block of ABL Diagnostics shares as part of an over-the-counter transaction with a private third party. The filing relating to this sale can be viewed...

SÃO PAULO--(BUSINESS WIRE)--Nu Holdings Ltd. (NYSE: NU) today announced that its Board of Directors has approved a share repurchase program of up to US$1.0 billion of the Company's Class A ordinary shares, to be conducted over a 12-month period beginning June 4, 2026. The program is the output of a deliberate capital allocation policy. Nu's operations are now generating significant capital, and the Board determined that repurchasing the Company's shares represents an attractive use of that capi...

CALGARY, Alberta--(BUSINESS WIRE)--Mainstreet Equity Corp. (“Mainstreet” or the “Corporation”) (TSX:MEQ) today announced that the Toronto Stock Exchange (“TSX”) has accepted its notice of intention to renew its normal course issuer bid (“NCIB”) to purchase outstanding common shares of the Corporation (“Shares”) on the open market in accordance with the rules of the TSX. The Corporation is authorized to purchase up to 471,066 Shares under the NCIB representing approximately 10% of its public flo...

LAVAL, Québec--(BUSINESS WIRE)--Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”) is pleased to announce the closing of the previously announced plan of arrangement (the “Arrangement”) with ClinActiv Holdings Inc. (“ClinActiv”) and its wholly-owned subsidiary (the “Purchaser”), pursuant to which the Purchaser acquired all the issued and outstanding common shares of the Company (the “Shares”) in exchange for cash consideration of $0.80 per Share (the “Consider...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aeva Technologies, Inc. (“Aeva” or the “Company”, Nasdaq: AEVA), a leader in next-generation sensing and perception systems, today announced the launch of a proposed follow-on public offering of $100,000,000 of shares of its common stock. The Company expects to grant the underwriters a 30-day option to purchase up to an additional $15,000,000 of shares of its common stock at the public offering price less the underwriting discounts and commissions. The of...